JUUL Granted Emergency Stay of FDA's Marketing Denial Order


The U.S. Court of Appeals for the D.C. Circuit on June 24 granted JUUL Labs Inc. an emergency administrative stay of the U.S. Food and Drug Administration's (FDA’s) marketing denial order (MDO) of all JUUL products. Retailers can continue to sell JUUL products while the company challenges the FDA’s MDO

FDA on June 23 issued an MDO to JUUL Labs Inc. for their products, including the JUUL device and four types of JUUL pods on the market. On June 24, JUUL Labs Inc. requested emergency interim relief from the U.S. Court of Appeals for the D.C. Circuit, arguing FDA’s MDO is arbitrary and capricious. In granting the emergency administrative stay, the court indicated JUUL Labs Inc. has until Monday to file its emergency motion in response to FDA's actions.

Retailers should continue to contact JUUL Labs Inc. with specific questions about products in their inventory. 

NATSO is monitoring this issue and will continue to provide information to members as it becomes available.

Media Contact:
Tiffany Wlazlowski Neuman
Vice President, Public Affairs
Phone: (703) 739-8578
Email: twlazlowski@natso.com

Subscribe to Updates

NATSO provides a breadth of information created to strengthen travel plazas’ ability to meet the needs of the travelling public in an age of disruption. This includes knowledge filled blog posts, articles and publications. If you would like to receive a digest of blog post and articles directly in your inbox, please provide your name, email and the frequency of the updates you want to receive the email digest.